HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Shiseido

This article was originally published in The Rose Sheet

Executive Summary

Reformulates Bio-Performance Advanced Super Revitalizer to add hyaluronic acid and "hydrolized keratin complex," which is composed of proteins derived from eggshell membranes. The protein complex "keeps skin refreshed and vital" and functions as an antioxidant, while the hyaluronic acid "brings vital moisturizer to dry, thirsty skin," the firm says. Available in March, the reformulated product is repackaged in a warm silver container with a top that is easier to grip, the company states. Shiseido also increases the size of the product to 50 mil from 40 mil but maintains the original $60 suggested retail price. Additionally, Shiseido currently is running its first U.S.-only ad campaign consisting of two one-page ads and a two-page spread featuring a line drawing of a face and the tagline "Over A Century of Skin Caring.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000221

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel